Cargando…
Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy
LMNA mutation is associated with type-2 familial partial lipodystrophy (FPLD2). The disease causes a disorder characterized by anomalous accumulation of body fat in humans. The dysfunction at the molecular level is triggered by a lamin A/C mutation, impairing the cell metabolism. In human fibroblast...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368940/ https://www.ncbi.nlm.nih.gov/pubmed/35955791 http://dx.doi.org/10.3390/ijms23158659 |
_version_ | 1784766300320432128 |
---|---|
author | Algieri, Cristina Bernardini, Chiara Trombetti, Fabiana Schena, Elisa Zannoni, Augusta Forni, Monica Nesci, Salvatore |
author_facet | Algieri, Cristina Bernardini, Chiara Trombetti, Fabiana Schena, Elisa Zannoni, Augusta Forni, Monica Nesci, Salvatore |
author_sort | Algieri, Cristina |
collection | PubMed |
description | LMNA mutation is associated with type-2 familial partial lipodystrophy (FPLD2). The disease causes a disorder characterized by anomalous accumulation of body fat in humans. The dysfunction at the molecular level is triggered by a lamin A/C mutation, impairing the cell metabolism. In human fibroblasts and preadipocytes, a trend for ATP production, mainly supported by mitochondrial oxidative metabolism, is detected. Moreover, primary cell lines with FPLD2 mutation decrease the mitochondrial ATP production if compared with the control, even if no differences are observed in the oxygen consumption rate of bioenergetic parameters (i.e., basal and maximal respiration, spare respiratory capacity, and ATP turnover). Conversely, glycolysis is only inhibited in FPLD2 fibroblast cell lines. We notice that the amount of ATP produced in the fibroblasts is higher than in the preadipocytes, and likewise in the control, with respect to FPLD2, due to a more active oxidative phosphorylation (OXPHOS) and glycolysis. Moreover, the proton leak parameter, which characterizes the transformation of white adipose tissue to brown/beige adipose tissue, is unaffected by FPLD2 mutation. The metabolic profile of fibroblasts and preadipocytes is confirmed by the ability of these cell lines to increase the metabolic potential of both OXPHOS and glycolysis under energy required independently by the FPLD2 mutation. |
format | Online Article Text |
id | pubmed-9368940 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93689402022-08-12 Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy Algieri, Cristina Bernardini, Chiara Trombetti, Fabiana Schena, Elisa Zannoni, Augusta Forni, Monica Nesci, Salvatore Int J Mol Sci Article LMNA mutation is associated with type-2 familial partial lipodystrophy (FPLD2). The disease causes a disorder characterized by anomalous accumulation of body fat in humans. The dysfunction at the molecular level is triggered by a lamin A/C mutation, impairing the cell metabolism. In human fibroblasts and preadipocytes, a trend for ATP production, mainly supported by mitochondrial oxidative metabolism, is detected. Moreover, primary cell lines with FPLD2 mutation decrease the mitochondrial ATP production if compared with the control, even if no differences are observed in the oxygen consumption rate of bioenergetic parameters (i.e., basal and maximal respiration, spare respiratory capacity, and ATP turnover). Conversely, glycolysis is only inhibited in FPLD2 fibroblast cell lines. We notice that the amount of ATP produced in the fibroblasts is higher than in the preadipocytes, and likewise in the control, with respect to FPLD2, due to a more active oxidative phosphorylation (OXPHOS) and glycolysis. Moreover, the proton leak parameter, which characterizes the transformation of white adipose tissue to brown/beige adipose tissue, is unaffected by FPLD2 mutation. The metabolic profile of fibroblasts and preadipocytes is confirmed by the ability of these cell lines to increase the metabolic potential of both OXPHOS and glycolysis under energy required independently by the FPLD2 mutation. MDPI 2022-08-04 /pmc/articles/PMC9368940/ /pubmed/35955791 http://dx.doi.org/10.3390/ijms23158659 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Algieri, Cristina Bernardini, Chiara Trombetti, Fabiana Schena, Elisa Zannoni, Augusta Forni, Monica Nesci, Salvatore Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy |
title | Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy |
title_full | Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy |
title_fullStr | Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy |
title_full_unstemmed | Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy |
title_short | Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy |
title_sort | cellular metabolism and bioenergetic function in human fibroblasts and preadipocytes of type 2 familial partial lipodystrophy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368940/ https://www.ncbi.nlm.nih.gov/pubmed/35955791 http://dx.doi.org/10.3390/ijms23158659 |
work_keys_str_mv | AT algiericristina cellularmetabolismandbioenergeticfunctioninhumanfibroblastsandpreadipocytesoftype2familialpartiallipodystrophy AT bernardinichiara cellularmetabolismandbioenergeticfunctioninhumanfibroblastsandpreadipocytesoftype2familialpartiallipodystrophy AT trombettifabiana cellularmetabolismandbioenergeticfunctioninhumanfibroblastsandpreadipocytesoftype2familialpartiallipodystrophy AT schenaelisa cellularmetabolismandbioenergeticfunctioninhumanfibroblastsandpreadipocytesoftype2familialpartiallipodystrophy AT zannoniaugusta cellularmetabolismandbioenergeticfunctioninhumanfibroblastsandpreadipocytesoftype2familialpartiallipodystrophy AT fornimonica cellularmetabolismandbioenergeticfunctioninhumanfibroblastsandpreadipocytesoftype2familialpartiallipodystrophy AT nescisalvatore cellularmetabolismandbioenergeticfunctioninhumanfibroblastsandpreadipocytesoftype2familialpartiallipodystrophy |